Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome
- 23 December 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (5) , 7435-7447
Abstract
Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility in child‐bearing‐age women. It is characterized by ovulation dysfunction, polycystic ovaries, and hyperandrogenism. Inflammation is likely to be a crucial contributor to the pathogenesis of PCOS. However, the association between the inflammatory cytokines and the development of PCOS has not been reported. To explore the relationship between the inflammatory cytokines and PCOS, alterations of serum proteins in dehydroepiandrosterone (DHEA)‐induced PCOS rats were screened by protein array, and the concentration of IFN‐γ was further measured by using enzyme‐linked immunosorbent assay (ELISA). DHEA‐induced PCOS rats had a decreased level of IFN‐γ compared with the control rats, which was restored partly in flutamide (an androgen receptor antagonist)‐treated rats. Moreover, the level of IFN‐γ in serum of patients with PCOS was also lower than that in healthy women. Using the ovarian granulosa cells (KGN), we demonstrated that DHEA downregulated the expression and secretion of IFN‐γ in dose‐ and time‐dependent manners, which could be restored to some extent by treating with flutamide. Furthermore, flutamide ameliorated the inhibitory effect on cell proliferation and promotive effect on cell apoptosis by DHEA. The results also revealed that IFN‐γ promoted the proliferation but inhibited the apoptosis of KGN cells, which was suppressed by DHEA via activating the downstream PI3K/AKT signaling pathway. Taken together, these results showed that DHEA inhibited the proliferation and promoted the apoptosis of ovarian granulosa cells through downregulating the expression of IFN‐γ which could be restored by flutamide, and IFN‐γ may serve as a potential inflammatory biomarker for PCOS detection.Keywords
Funding Information
- National Natural Science Foundation of China (31670810, 31870794, 31770857)
This publication has 32 references indexed in Scilit:
- Hyperandrogenism sensitizes mononuclear cells to promote glucose-induced inflammation in lean reproductive-age womenAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Androgen administration in normal reproductive-age women promotes proatherogenic inflammation as characterized in polycystic ovary syndrome (PCOS)Fertility and Sterility, 2011
- Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH testHuman Reproduction, 2011
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosisNature Reviews Endocrinology, 2011
- Cardiovascular risk in postmenopausal women with the polycystic ovary syndromeMaturitas, 2011
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypesFertility and Sterility, 2010
- Plasma monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatmentClinical Endocrinology, 2009
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force reportFertility and Sterility, 2009
- Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathwayExperimental Cell Research, 2006
- PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic–pituitary–adrenal axis?European Journal of Obstetrics & Gynecology and Reproductive Biology, 2005